BIO News and Press, Bio-Rad Laboratories Inc. Class A From 03/21/24

2024-03-21 01:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-20 08:35:53 ET More on Bio-Rad Labs Danaher, Repligen rise as German peer Sartorius beats in Q4 Seeking Alpha’s Quant Rating on Bio-Rad Labs Historical earnings data for Bio-Rad Labs Read the full article on Seeking Alpha For further de...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Roop K. Lakkaraju will join the company as its new Executive Vice President and Chief Financial Officer, effective April 15, 2024. Mr. Lakkaraju j...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company’s management will participate in a fireside chat event during Citi's 2024 Unplugged Medtech and Life Sciences Access Day on Thursda...

2024-02-17 05:07:49 ET Bio-Rad, a multinational manufacturer, focuses on selling diverse products globally for recurring revenues. Despite economic uncertainty, management prioritizes standardization and government support. They manage cybersecurity risks proactively with a dedicated security...

2024-02-16 18:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-15 18:54:02 ET Bio-Rad Laboratories, Inc. (BIO) Q4 2023 Earnings Conference Call February 15, 2024, 5:00 PM ET Company Participants Edward Chung - Head, Investor Relations Norman Schwartz - Chief Executive Officer Andy Last - Executive Vice President and ...

2024-02-15 16:43:22 ET More on Bio-Rad Labs Bio-Rad Labs Q4 2023 Earnings Preview Danaher, Repligen rise as German peer Sartorius beats in Q4 Seeking Alpha’s Quant Rating on Bio-Rad Labs Historical earnings data for Bio-Rad Labs Financial infor...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full year ended December 31, 2023. Fourth-quarter 2023 total net sales were $681.2 million, a decrease of ...

Propanc Biopharma Inc (PPCB) is expected to report for Q2 2024 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 Arch Resources Inc. Class A (ARCH) is expected to report $6.9 for Q4 2023 Bloom Energy Corporation Class A (BE) is expected to report $-0.0...